From April 9 to 12, 2026, the 93rd China International Medical Equipment Fair (CMEF) grandly opened at the National Exhibition and Convention Center in Shanghai.
At present, China's medical X-ray tube industry has been through the 1.0 and 2.0 era of "import dependence · domestic germination" of "mid-end catch-up · large-scale volume expansion", and officially entered the new 3.0 era of "high-end breakthrough · independent control". The key themes of industrial development have shifted from "from 0 to 1" and "from less to more" to "high-end technology, independent manufacturing, and benchmark quality".
At this grand industry event, Guochen Medical showcased its cutting-edge technological achievements and full-range core products, focusing on high-end OM tubes and liquid bearing product families. It attracted extensive attention from global industry peers, medical institutions and complete machine manufacturers, demonstrating the strong development momentum of domestic medical devices.
Breakthrough in High-end 0M Tube Technology
The debut of CTA001 marks the first time Guochen's high-end 0M tube technology has moved from behind-the-scenes R&D to the industrial forefront, representing a major milestone in the development of Guochen Medical. We hope this will inspire and further advance the high-end development of core components in domestic X-ray tubes, injecting strong impetus into the high-end upgrading of China's medical imaging industry.
The CTA001 series has achieved high-end domestic production of core raw materials and manufacturing processes, breaking away from dependence on imported special metals, precision processing equipment and technologies. It fills the domestic technological gap in the field of high-end 0M tubes, and provides domestic imaging equipment manufacturers with cost-effective and highly reliable high-end localized solutions.
Expansion of Liquid Bearing Product Matrix
Guochen Medical has continuously deepened its layout in the liquid bearing sector. The liquid bearing product family, represented by CTA50L1, CTA60L1, CTA70L1 and CTA70L2, has been continuously enriched, building a multi-category product system covering the mid-to-high-end markets of brands such as Canon, Siemens and GE. This forms two-way empowerment with the breakthrough in high-end OM tube technology, and also serves as an important support for the high-end and diversified development of Guochen's product matrix.
Building a Sustainable Industrial Ecosystem
The breakthrough and leapfrog technological development of Guochen Medical is a phased achievement of adhering to an open and inclusive mindset, basing itself on the overall development of the domestic core component industry, actively linking up with upstream and downstream industrial chain partners, and jointly creating a healthy and sustainable industrial ecosystem. It is an important attempt of "collaborative symbiosis and common upgrading" in the "involution era".
In recent years, Guochen Medical has introduced 15 professional manufacturers in the raw material processing of ball bearings, liquid metal bearings, target disks, filaments, ceramics, glass shells and other fields; introduced and assisted 6 enterprises in equipment customization in the field of high-end non-standard equipment such as production equipment, process equipment and special process customized equipment; established 6 forward-looking technology laboratories and launched 12 special research projects, breaking through and optimizing various professional technologies.We have completely abandoned the old development model of isolated fighting, homogeneous competition and massive redundant construction, shared resources, solved problems together, promoted industrial upgrading, and fostered a new industrial pattern of "collaborative innovation, symbiosis and common prosperity".
Dual-center Strategy, Active Participation in Global Competition
High-end product development is an inevitable outcome of technological progress, and participation in global competition is the only way for market development. Guochen Medical has been actively expanding markets in Southeast Asia, the Middle East, Latin America and other regions, with a steady increase in overseas revenue proportion. It has established dealer networks and after-sales service systems in many countries and regions around the world, realizing the leap from "product going global" to "brand going global" and "service going global".
The company has obtained multiple international qualifications such as FDA and EAEU, and is expected to achieve regional registration certifications in 25 major markets in 2026, gradually breaking the cognitive barriers of international markets towards Chinese brands.
At the end of 2025, Guochen Medical's Hainan Global Service Center was established, marking the official entry of Guochen Medical into the dual-center operation era with Wuxi R&D and Production Center as the cornerstone and Hainan Global Service Center as the anchor point.
Wuxi R&D and Manufacturing Center will continue to increase R&D investment, deepen core technological innovation, improve the product matrix, and consolidate the core foundation of domestic intelligent manufacturing. Relying on the policy advantages of Hainan Free Trade Port, Hainan Global Service Center will build a global service network, improve overseas service efficiency, and expand global market layout.
The development path of domestic substitution in the CT tube industry in the 3.0 era has become clear. Guochen Medical's strategic layout is in resonance with industrial development. "Establishing Chinese brands, serving global people's livelihood" is our responsibility and mission.
